StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Price Performance NASDAQ VTVT opened at $0.47 on Friday. The company has a market cap of $48.94 million, a PE ratio of -1.95 […]
Related Keywords
, Millennium Management , Prudential Financial Inc , Sorce Advisory , Tv Therapeutics Inc , Free Report , Get Free Report , Street Corp , Vtv Therapeutics , Nasdaq Vtvt , Vtvt , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.